TREATMENT OF ALCOHOLISM AS A CHRONIC DISORDER

被引:19
作者
OBRIEN, CP
机构
关键词
ALCOHOLICS ANONYMOUS; BETA-ENDORPHIN; COMPLIANCE; CRAVING; DISULFIRAM; DOUBLE-BLIND; ENDOGENOUS OPIOID; EUPHORIA; MORPHINE; NALTREXONE; OPIATE RECEPTOR; PLACEBO; REHABILITATION; RELAPSE;
D O I
10.1016/0741-8329(94)90063-9
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Alcoholism is a common disorder that tends to be chronic and relapsing. Although there is clear evidence that treatment can be expected to induce a period of remission or at least decreased symptoms, treatment of alcoholism is generally regarded as unsuccessful. Alcoholism should be approached as a chronic medical disorder such as diabetes or arthritis. Complete abstinence is the preferred goal, but ''cures'' or permanent abstinence from alcohol are rate. In this model, treatment benefits may be measured by length of remission, reduction in alcohol use, improvement in health and enhancement of social functioning. Treatment continues over a period of years, mainly on an outpatient basis with increasing intensity if symptoms recur. Medications that reduce craving for alcohol or diminish the euphoric effects of alcohol would be very helpful in the management of this chronic disorder. Preclinical studies have produced evidence for involvement of the endogenous opioid system in the reinforcing effects of alcohol. Recent controlled clinical trials of the opiate receptor antagonist naltrexone suggest that medications of this type may improve the results of treatment for alcoholism.
引用
收藏
页码:433 / 437
页数:5
相关论文
共 21 条
  • [1] ALTERATION OF ETHANOL SELF-ADMINISTRATION BY NALTREXONE
    ALTSHULER, HL
    PHILLIPS, PE
    FEINHANDLER, DA
    [J]. LIFE SCIENCES, 1980, 26 (09) : 679 - 688
  • [2] NALOXONE ATTENUATES VOLUNTARY ETHANOL INTAKE IN RATS SELECTIVELY BRED FOR HIGH ETHANOL PREFERENCE
    FROEHLICH, JC
    HARTS, J
    LUMENG, L
    LI, TK
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (02) : 385 - 390
  • [3] DISULFIRAM FOR THE TREATMENT OF ALCOHOLISM - EVALUATION IN 128 MEN
    FULLER, RK
    ROTH, HP
    [J]. ANNALS OF INTERNAL MEDICINE, 1979, 90 (06) : 901 - 904
  • [4] GIANOULAKIS C, 1990, OPIOIDS, BULIMIA, AND ALCOHOL ABUSE & ALCOHOLISM, P229
  • [5] HUBBLE CL, 1985, ALCOHOL, V5, P409
  • [6] DECREASE IN ETHANOL-CONSUMPTION BY NALOXONE IN NAIVE AND DEPENDENT RATS
    MARFAINGJALLAT, P
    MICELI, D
    LEMAGNEN, J
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 18 : 537 - 539
  • [7] McKay J. R., 1993, DRUGS SOC, V8, P1, DOI [10.1300/J023v08n01_01, DOI 10.1300/J023V08N01_01]
  • [8] A NEW MEASURE OF SUBSTANCE-ABUSE TREATMENT - INITIAL STUDIES OF THE TREATMENT SERVICES REVIEW
    MCLELLAN, AT
    ALTERMAN, AI
    CACCIOLA, J
    METZGER, D
    OBRIEN, CP
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1992, 180 (02) : 101 - 110
  • [9] MCLELLAN AT, 1992, ADDICT STATES, P231
  • [10] THE EFFECTIVENESS OF TREATMENT FOR SUBSTANCE-ABUSE - REASONS FOR OPTIMISM
    MILLER, WR
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1992, 9 (02) : 93 - 102